Clorox Company (The) (CLX) Holdings Raised by Pinkerton Retirement Specialists LLC

Pinkerton Retirement Specialists LLC raised its holdings in shares of Clorox Company (The) (NYSE:CLX) by 2.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,387 shares of the company’s stock after acquiring an additional 401 shares during the quarter. Clorox makes up about 1.2% of Pinkerton Retirement Specialists LLC’s investment portfolio, making the stock its 28th biggest position. Pinkerton Retirement Specialists LLC’s holdings in Clorox were worth $2,387,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of CLX. Janus Henderson Group PLC raised its holdings in Clorox by 8,008.5% during the second quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock valued at $176,340,000 after acquiring an additional 1,307,153 shares during the period. Vanguard Group Inc. raised its holdings in Clorox by 2.6% during the second quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock valued at $1,936,595,000 after acquiring an additional 369,918 shares during the period. APG Asset Management N.V. raised its holdings in Clorox by 30.9% during the third quarter. APG Asset Management N.V. now owns 1,301,915 shares of the company’s stock valued at $171,736,000 after acquiring an additional 307,700 shares during the period. Ameriprise Financial Inc. raised its holdings in Clorox by 24.6% during the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock valued at $178,433,000 after acquiring an additional 265,200 shares during the period. Finally, Renaissance Technologies LLC raised its holdings in Clorox by 24.5% during the second quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock valued at $178,728,000 after acquiring an additional 263,700 shares during the period. 73.42% of the stock is currently owned by institutional investors and hedge funds.

Clorox Company (NYSE:CLX) opened at $145.05 on Thursday. The company has a market capitalization of $18,652.26, a PE ratio of 26.07, a P/E/G ratio of 3.93 and a beta of 0.43. Clorox Company has a 12-month low of $113.95 and a 12-month high of $145.32. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.41 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.48 billion. Clorox had a return on equity of 161.59% and a net margin of 11.84%. The firm’s revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the business posted $1.36 earnings per share. analysts expect that Clorox Company will post 5.6 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be given a $0.84 dividend. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 annualized dividend and a yield of 2.32%. Clorox’s dividend payout ratio is currently 61.88%.

A number of research analysts have recently weighed in on the company. BMO Capital Markets restated a “buy” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, October 5th. Morgan Stanley cut their price objective on Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a research report on Thursday, November 2nd. Jefferies Group restated a “hold” rating and set a $132.00 price objective on shares of Clorox in a research report on Wednesday, November 1st. Royal Bank Of Canada restated a “hold” rating and set a $115.00 price objective on shares of Clorox in a research report on Sunday, October 8th. Finally, Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Monday, November 6th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $128.72.

In other Clorox news, SVP Matthew T. Laszlo sold 20,051 shares of the firm’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the sale, the senior vice president now owns 10,896 shares of the company’s stock, valued at $1,421,492.16. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Michael R. Costello sold 10,574 shares of the firm’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the sale, the senior vice president now directly owns 34,867 shares of the company’s stock, valued at approximately $4,742,260.67. The disclosure for this sale can be found here. Company insiders own 1.00% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This report was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this report on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this report can be viewed at https://sportsperspectives.com/2017/12/07/clorox-company-the-clx-holdings-raised-by-pinkerton-retirement-specialists-llc.html.

Clorox Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply